Clinical Trial Update: Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study) [Phase 3]

View source ↗

Summary

The AVALANCHE Phase 3 trial compares rosiglitazone-based regimens (Avandia + Amaryl or Avandamet) with metformin in Type 2 diabetes and has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Avandamet (rosiglitazone/metformin)
• Avandia (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: Canadian Heart Research Centre | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-04-17